Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuhan Zhang

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Pediatric Transplantation|November 8, 2021
Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine-busulfan-cyclophosphamide-based conditioningGuifang Li, Zimin Sun, Liangquan Geng, et al.
Blood Advances|August 14, 2020
Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantationBaolin Tang, Lulu Huang, Huilan Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2017
Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in ChinaJuan Tong, Li Xuan, Yanling Sun, et al.
The Lancet. Haematology|October 19, 2025
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 studyQianwen Xu, Yugang Guo, Min Gao, et al.
Cancer Biology & Medicine|October 1, 2019
Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57<sup>CDKN1C</sup> and TP53INP1 in mantle cell lymphomaWei Li, Chengfeng Bi, Yating Han, et al.
Frontiers in Immunology|May 13, 2022
Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T CellsQianwen Xu, Lei Xue, Furun An, et al.
Hematological Oncology|May 11, 2019
Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomasXuhan Zhang, Lu Liu, Shiyong Zhou, et al.
International Journal of Cancer|January 22, 2019
Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcomeXianhuo Wang, Tingting Zhang, Zheng Song, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 10, 2018
Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCLLinyu Li, Xuhan Zhang, Tingting Zhang, et al.
International Journal of Cancer|February 24, 2018
Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) studyZimin Sun, Huilan Liu, Chenhui Luo, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Pediatric Transplantation|November 8, 2021
Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine-busulfan-cyclophosphamide-based conditioningGuifang Li, Zimin Sun, Liangquan Geng, et al.
Blood Advances|August 14, 2020
Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantationBaolin Tang, Lulu Huang, Huilan Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2017
Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in ChinaJuan Tong, Li Xuan, Yanling Sun, et al.
The Lancet. Haematology|October 19, 2025
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 studyQianwen Xu, Yugang Guo, Min Gao, et al.
Cancer Biology & Medicine|October 1, 2019
Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57<sup>CDKN1C</sup> and TP53INP1 in mantle cell lymphomaWei Li, Chengfeng Bi, Yating Han, et al.
Frontiers in Immunology|May 13, 2022
Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T CellsQianwen Xu, Lei Xue, Furun An, et al.
Hematological Oncology|May 11, 2019
Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomasXuhan Zhang, Lu Liu, Shiyong Zhou, et al.
International Journal of Cancer|January 22, 2019
Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcomeXianhuo Wang, Tingting Zhang, Zheng Song, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 10, 2018
Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCLLinyu Li, Xuhan Zhang, Tingting Zhang, et al.
International Journal of Cancer|February 24, 2018
Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) studyZimin Sun, Huilan Liu, Chenhui Luo, et al.
Pageof 5